Donna Hallas discusses the Pfizer-BioNTech vaccine booster for children 5 to 11 years old

Article

Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.

In a video for Contemporary Pediatrics®, Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discussed the recent FDA amendment of the current emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine which is now authorizing a single booster dose for children 5-11 years old. The Booster will be available to children of this age at least 5 months after completing the primary vaccine series.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Experts discuss importance of vaccination prior to school year
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Lori Handy, MD: Vaccine-only visits can help ease back-to-school gaps | Image credit: CHOP
© 2025 MJH Life Sciences

All rights reserved.